Our President and CEO, Daozhan Yu, had the honor of moderating the CMC Panel at the Advancing Precision Mdicine Conference in Philadelphia.
Panel Highlights:
🔹 Industry Experts: Joined by leaders from Spark Therapeutics and CoJourney Bio
🔹 Discussions: FDA’s tightening CMC quality standards, real-world CMC challenges, and the debate on in-house management vs. CDMO partnerships for quality and compliance
🔹 Insights: Quality control, regulatory best practices, and innovations in AAV characterization
Panelists:
- Xuguang Chen, Ph.D., Manager, Upstream Process Development, Spark Therapeutics
- Tim Zhou, Ph.D., Manager, Downstream/Formulation Development, Spark Therapeutics
- Jasmina Cheung Lau, Ph.D., Lead Scientist, Analytical Program Development, Spark Therapeutics
- Lijun Wang, Ph.D., CEO, CoJourney Bio
#GeneTherapy #CMC #DrugDevelopment #PrecisionMedicine #AdvancingMedicine #Conference #Biotech #AAV #FDA #CDMO #Pharma
